How to Pronounce Wegovy in English

Where the pronunciation comes from, and why it's worth knowing

Novo Nordisk has never published a formal etymology for the name Wegovy, but the phonetics are unambiguous. Every major English-speaking health authority, including the NHS, renders it WEE-go-vee. The NHS medicines page for semaglutide lists Wegovy as a brand name for the weight-loss indication, and clinical staff across the UK use that three-syllable pronunciation consistently.

The stress pattern matters more than it might seem. Some people, having read the name before hearing it, land the emphasis on the second syllable ('weh-GO-vee') which sounds slightly off to a GP or pharmacist and can briefly create confusion in consultations. Getting it right is a small but genuine confidence-builder when you're discussing treatment options with a clinician.

For reference, the international non-proprietary name for the active ingredient is semaglutide, pronounced seh-MAG-loo-tide. You'll hear both names used in clinical settings: prescribers often say semaglutide when talking mechanism; they say Wegovy when they mean the specific weight-management licensed product as distinct from Ozempic, which contains the same molecule but is licensed for type 2 diabetes. The distinction matters clinically, not just linguistically. You can read more about semaglutide as a medicine if that side of things interests you.

A question our prescribers hear most weeks, and the confusion behind it

How do you pronounce Wegovy in English? It comes up surprisingly often, and usually for the same reason: people encounter the name in writing first, whether in a news article, a GP letter, or a pharmacy leaflet, before they ever hear a clinician say it aloud. Brandnames built from invented syllables don't always follow obvious phonetic rules, and 'Wegovy' looks like it could go several ways on the page.

The short answer is that it rhymes roughly with 'we go free', compressed to three quick syllables, and our guide to how to pronounce Wegovy walks through each syllable in detail if you'd like a fuller breakdown. British and American English speakers land on the same sounds here, there's no transatlantic variation worth worrying about. The pronunciation of Wegovy in English is stable across accents, which makes it straightforward to use confidently in any clinical setting.

One related source of confusion: some people arrive having heard of 'the skinny jab' and aren't sure whether Wegovy, Ozempic, and semaglutide are three different drugs or three names for the same thing. They're not all the same. Semaglutide is the molecule; Wegovy is the weight-management brand; Ozempic is the diabetes brand. Only Wegovy is licensed in the UK for weight loss. Our Wegovy overview covers the distinction in full if you want the detail.

What the MHRA approval means for the UK name (and who can prescribe it

The MHRA licensed Wegovy for weight management in the UK, and the name on the UK marketing authorisation is Wegovy) not Rybelsus, not Ozempic, not any other semaglutide brand. This is clinically significant: NICE's appraisal of semaglutide for weight management, TA875, applies specifically to Wegovy in that licensed indication, setting out criteria including BMI thresholds and the requirement for use within a specialist weight management service on the NHS.

Private access works differently. A GPhC-registered Independent Prescriber can prescribe Wegovy following a clinical assessment without the NHS pathway or waiting list. At nume, a real prescriber reads your consultation the same day, not software, not a triage queue. If the medicine is appropriate, it's dispatched the same day for free next-working-day delivery. If you're thinking about whether Wegovy might suit you, the right place to start is a free consultation with our prescribers.

From April 2026, GP practices may also prescribe tirzepatide (Mounjaro) under the NHS contract, which has shifted some attention away from semaglutide, but Wegovy remains a licensed and widely prescribed option. The availability of Wegovy in England is worth understanding if you're weighing NHS versus private routes. Wegovy now also comes in a 7.2mg dose approved by the MHRA in early 2026, which narrows the gap with tirzepatide's results in trials. Dose and formulation discussions belong with your prescriber, not a search engine.

Wegovy versus Zepbound (a name that comes up online and what it means for UK readers

If you've been researching weight-loss medicines and encountered 'Zepbound', that's the US brand name for tirzepatide) the active ingredient in Mounjaro, which is how it's sold in the UK. Zepbound does not exist as a UK product. It isn't available from UK pharmacies. The naming difference matters because US and UK versions of these medicines sometimes carry different dosing conventions, pricing structures, and prescribing rules. Content written for a US audience doesn't translate cleanly to the UK context.

Similarly, Rybelsus is oral semaglutide but licensed for type 2 diabetes at lower doses, not the same as the Wegovy tablet, which received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. Understanding how Wegovy is accessed in the UK, who it's licensed for, and what the clinical process looks like is the foundation for any conversation with a prescriber. Getting the name right is just the start.